
John Strickler, MD, discusses targeting c-Met as a biomarker in gastric and gastroesophageal junction cancers.

Your AI-Trained Oncology Knowledge Connection!

John Strickler, MD, is a medical oncologist with a focus on gastrointestinal cancers at Duke Cancer Center in Durham, NC.

Published: October 12th 2024 | Updated: